Filters
reset allOther countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
MSRB3 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 1 | 1 |
|
Centogene US, LLC - The Rare Disease Company United States | 203 | 194 |
|
Centogene US, LLC - The Rare Disease Company United States | 323 | 329 |
|
Centogene US, LLC - The Rare Disease Company United States | 406 | 414 |
|
Centogene US, LLC - The Rare Disease Company United States | 1886 | 1858 |
|
MSRB3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 323 | 329 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
Centogene AG - the Rare Disease Company Germany | 203 | 194 |
|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 288 | 218 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics United States | 356 | 211 |
|
Deafness, Autosomal Recessive 74 (DFNB74) via the MSRB3 Gene PreventionGenetics United States | 1 | 1 |
|
Deafness, autosomal recessive 74 (sequence analysis of MSRB3 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Non-syndromic hearing loss panel. 95-gene NGS panel. Genologica Medica Spain | 146 | 94 |
|
Autosomal recessive hearing loss. 41-gene NGS panel. Genologica Medica Spain | 65 | 41 |
|
Hearing Loss, Comprehensive Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 142 | 84 |
|
Deafness, autosomal recessive: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 75 | 75 |
|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.